Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Standard Biotools (LAB) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Standard Biotools (LAB) over the last 15 years, with Q3 2025 value amounting to 0.38%.

  • Standard Biotools' Return on Capital Employed fell 1300.0% to 0.38% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.38%, marking a year-over-year decrease of 1300.0%. This contributed to the annual value of 0.44% for FY2024, which is 1300.0% down from last year.
  • Standard Biotools' Return on Capital Employed amounted to 0.38% in Q3 2025, which was down 1300.0% from 0.34% recorded in Q2 2025.
  • Standard Biotools' 5-year Return on Capital Employed high stood at 0.21% for Q1 2021, and its period low was 0.38% during Q3 2025.
  • Moreover, its 5-year median value for Return on Capital Employed was 0.3% (2025), whereas its average is 0.29%.
  • As far as peak fluctuations go, Standard Biotools' Return on Capital Employed tumbled by -1400bps in 2021, and later skyrocketed by 500bps in 2024.
  • Quarter analysis of 5 years shows Standard Biotools' Return on Capital Employed stood at 0.29% in 2021, then fell by -10bps to 0.32% in 2022, then decreased by -7bps to 0.35% in 2023, then grew by 5bps to 0.33% in 2024, then dropped by -14bps to 0.38% in 2025.
  • Its Return on Capital Employed stands at 0.38% for Q3 2025, versus 0.34% for Q2 2025 and 0.3% for Q1 2025.